Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Previously submitted to: Journal of Medical Internet Research (no longer under consideration since Oct 09, 2022)

Date Submitted: Apr 11, 2022

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Your MS Questionnaire: A Patient-based Digital Tool to Monitor Symptoms of Multiple Sclerosis

  • Gavin Giovannoni; 
  • Enrique Alvarez; 
  • Ellen Tutton; 
  • Olaf Hoffmann; 
  • Yan Xu; 
  • Patrick Vermersch; 
  • Celia Oreja-Guevara; 
  • Maria Trojano; 
  • Ralf Gold; 
  • René Robles-Cedeño; 
  • Mudeer Khwaja; 
  • Bianca Stadler; 
  • Jo Vandercappellen; 
  • Tjalf Ziemssen

ABSTRACT

Background:

The Your Multiple Sclerosis Questionnaire (YMSQ; www.yourms.com), a patient-completed tool, was co-developed with people living with MS (plwMS), patient advocacy groups, and clinicians to capture MS symptom changes and facilitate discussion between plwMS and clinicians.

Objective:

We describe the development of YMSQ and present the real-world usability testing results of YMSQ conducted across 7 countries.

Methods:

The YMSQ tool was developed in 4 stages to collect feedback from plwMS, patient organizations, and clinicians on content, format, and applicability. To assess its usability, 13 clinicians across 7 countries completed an online survey after using the tool with plwMS in a total of 261 consultations from September, 2020 to July, 2021.

Results:

The initial YMSQ version was based on findings from previous research developing MSProDiscuss™, a clinician-completed tool. Subsequently, insights from plwMS obtained during cognitive debriefing, patient councils and advisory boards led to changes including the addition of mood and sexual problems and the definition of relapse. All 13 clinicians completed the individual survey, whereas 10 clinicians completed the final survey. Clinicians “strongly agreed” or “agreed” that YMSQ was easy to use and understand (98.5%; 257/261 patient consultations). The clinicians were willing to use the tool again with the same patient (98.1%; 256/261 patient consultations). All clinicians who completed the final survey (100%; 10/10) reported that the use of the tool had a positive influence on their clinical practice, helped patients engage with their MS, facilitated discussion with patients, and complemented neurological assessment.

Conclusions:

YMSQ benefits both plwMS and clinicians by facilitating a structured discussion and engaging the plwMS to self-monitor and self-manage. YMSQ is compatible with telemedicine practice and integration of the tool into electronic health records would enable tracking of the disease evolution and individual monitoring of MS symptoms over time.


 Citation

Please cite as:

Giovannoni G, Alvarez E, Tutton E, Hoffmann O, Xu Y, Vermersch P, Oreja-Guevara C, Trojano M, Gold R, Robles-Cedeño R, Khwaja M, Stadler B, Vandercappellen J, Ziemssen T

Your MS Questionnaire: A Patient-based Digital Tool to Monitor Symptoms of Multiple Sclerosis

JMIR Preprints. 11/04/2022:38646

DOI: 10.2196/preprints.38646

URL: https://preprints.jmir.org/preprint/38646

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.